Dr Michael Garza, PHD - Medicare Psychologist in Manhattan, KS

Dr Michael Garza, PHD is a medicare enrolled "Psychologist - Counseling" provider in Manhattan, Kansas. His current practice location is 720 Poyntz Ave, Manhattan, Kansas. You can reach out to his office (for appointments etc.) via phone at (785) 320-7331.

Dr Michael Garza is licensed to practice in Kansas (license number LP03222) and he also participates in the medicare program. He does not accept medicare assignments directly but he may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. His NPI Number is 1275141434.

Contact Information

Dr Michael Garza, PHD
720 Poyntz Ave,
Manhattan, KS 66502-6355
(785) 320-7331
Not Available



Healthcare Provider's Profile

Full NameDr Michael Garza
GenderMale
SpecialityPsychologist - Counseling
Location720 Poyntz Ave, Manhattan, Kansas
Accepts Medicare AssignmentsMedicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1275141434
  • Provider Enumeration Date: 07/14/2020
  • Last Update Date: 06/01/2023
  Medicare PECOS Information:
  • PECOS PAC ID: 5294145496
  • Enrollment ID: I20201029000190

Medical Identifiers

Medical identifiers for Dr Michael Garza such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1275141434NPI-NPPES
LP03222OtherKSLICENSE

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
103TC1900XPsychologist - Counseling LP03222 (Kansas)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Michael Garza allows following entities to bill medicare on his behalf.
Entity NameCommunity Health Center Of Southeast Kansas Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1669474425
PECOS PAC ID: 7911816392
Enrollment ID: O20040209000163

News Archive

Chimerix announces completion of $45 million Series F financing

Chimerix, Inc., a pharmaceutical company developing orally-available broad spectrum antiviral therapeutics, today announced the completion of a $45 million Series F financing. New Leaf Venture Partners led the round, with participation by new investors Pappas Ventures and Morningside Group, as well as existing investors Canaan Partners, Sanderling Ventures, Alta Partners, Asset Management Company and Frazier Healthcare Ventures.

Canadians paralysed after drinking carrot juice

Carrot juice which was withdrawn from the market late last month is thought to be responsible for the illness of two Canadians who are paralyzed and are severely ill in hospital.

Medtronic plans IN.PACT Global drug-eluting balloon SFA clinical study

In conjunction with the Charing Cross International Symposium (CX34), which concludes today in London, Minneapolis-based Medtronic, Inc. announced its plans for the imminent start of the IN.PACT Global SFA clinical study, an international research program to evaluate the treatment of peripheral artery disease using the company's IN.PACT Admiral drug-eluting balloon.

Physical activity outside of work reduces risk of depression: Study

Researchers have found evidence that regular exercise reduces the risk of depression provided the activity is carried out in leisure time. People who exert themselves at work, for instance by digging up roads or heavy lifting, were no less likely to suffer depression than those in sedentary desk jobs.

Study examines impact of microvascular decompression surgery for type 2 diabetes

A team of Allegheny General Hospital (AGH) physicians led by neurosurgical pioneer Peter Jannetta, MD, has made an important new discovery linking the central nervous system to the onset and progression of type 2 diabetes mellitus.Reporting today in the journal Surgical Neurology International, Dr. Jannetta and his colleagues present evidence from a prospective clinical trial that vascular compression of a section of the brain called the medulla oblongata is a factor in some patients with type 2 diabetes and that microvascular decompression surgery (MVD) may be an effective treatment for the condition.

Read more Medical News

› Verified 1 days ago

Entity NameKaties Way Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1881096428
PECOS PAC ID: 1254664279
Enrollment ID: O20190606001608

News Archive

Chimerix announces completion of $45 million Series F financing

Chimerix, Inc., a pharmaceutical company developing orally-available broad spectrum antiviral therapeutics, today announced the completion of a $45 million Series F financing. New Leaf Venture Partners led the round, with participation by new investors Pappas Ventures and Morningside Group, as well as existing investors Canaan Partners, Sanderling Ventures, Alta Partners, Asset Management Company and Frazier Healthcare Ventures.

Canadians paralysed after drinking carrot juice

Carrot juice which was withdrawn from the market late last month is thought to be responsible for the illness of two Canadians who are paralyzed and are severely ill in hospital.

Medtronic plans IN.PACT Global drug-eluting balloon SFA clinical study

In conjunction with the Charing Cross International Symposium (CX34), which concludes today in London, Minneapolis-based Medtronic, Inc. announced its plans for the imminent start of the IN.PACT Global SFA clinical study, an international research program to evaluate the treatment of peripheral artery disease using the company's IN.PACT Admiral drug-eluting balloon.

Physical activity outside of work reduces risk of depression: Study

Researchers have found evidence that regular exercise reduces the risk of depression provided the activity is carried out in leisure time. People who exert themselves at work, for instance by digging up roads or heavy lifting, were no less likely to suffer depression than those in sedentary desk jobs.

Study examines impact of microvascular decompression surgery for type 2 diabetes

A team of Allegheny General Hospital (AGH) physicians led by neurosurgical pioneer Peter Jannetta, MD, has made an important new discovery linking the central nervous system to the onset and progression of type 2 diabetes mellitus.Reporting today in the journal Surgical Neurology International, Dr. Jannetta and his colleagues present evidence from a prospective clinical trial that vascular compression of a section of the brain called the medulla oblongata is a factor in some patients with type 2 diabetes and that microvascular decompression surgery (MVD) may be an effective treatment for the condition.

Read more Medical News

› Verified 1 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Michael Garza is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Michael Garza, PHD
720 Poyntz Ave,
Manhattan, KS 66502-6355

Ph: (785) 320-7331
Dr Michael Garza, PHD
720 Poyntz Ave,
Manhattan, KS 66502-6355

Ph: (785) 320-7331

News Archive

Chimerix announces completion of $45 million Series F financing

Chimerix, Inc., a pharmaceutical company developing orally-available broad spectrum antiviral therapeutics, today announced the completion of a $45 million Series F financing. New Leaf Venture Partners led the round, with participation by new investors Pappas Ventures and Morningside Group, as well as existing investors Canaan Partners, Sanderling Ventures, Alta Partners, Asset Management Company and Frazier Healthcare Ventures.

Canadians paralysed after drinking carrot juice

Carrot juice which was withdrawn from the market late last month is thought to be responsible for the illness of two Canadians who are paralyzed and are severely ill in hospital.

Medtronic plans IN.PACT Global drug-eluting balloon SFA clinical study

In conjunction with the Charing Cross International Symposium (CX34), which concludes today in London, Minneapolis-based Medtronic, Inc. announced its plans for the imminent start of the IN.PACT Global SFA clinical study, an international research program to evaluate the treatment of peripheral artery disease using the company's IN.PACT Admiral drug-eluting balloon.

Physical activity outside of work reduces risk of depression: Study

Researchers have found evidence that regular exercise reduces the risk of depression provided the activity is carried out in leisure time. People who exert themselves at work, for instance by digging up roads or heavy lifting, were no less likely to suffer depression than those in sedentary desk jobs.

Study examines impact of microvascular decompression surgery for type 2 diabetes

A team of Allegheny General Hospital (AGH) physicians led by neurosurgical pioneer Peter Jannetta, MD, has made an important new discovery linking the central nervous system to the onset and progression of type 2 diabetes mellitus.Reporting today in the journal Surgical Neurology International, Dr. Jannetta and his colleagues present evidence from a prospective clinical trial that vascular compression of a section of the brain called the medulla oblongata is a factor in some patients with type 2 diabetes and that microvascular decompression surgery (MVD) may be an effective treatment for the condition.

Read more News

› Verified 1 days ago


Psychologist in Manhattan, KS

Katharine Mcmillen, PH.D.
Psychologist
Medicare: Not Enrolled in Medicare
Practice Location: 500 N 4th St Apt 207, Manhattan, KS 66502
Phone: 516-675-7323    
Dr. Jane L. Tippet, PHD
Psychologist
Medicare: Accepting Medicare Assignments
Practice Location: 2001 Claflin Rd, Manhattan, KS 66502
Phone: 785-587-4300    Fax: 785-587-4305
Christine Ann Durrett, PHD
Psychologist
Medicare: Accepting Medicare Assignments
Practice Location: 2505 Anderson Ave, Suite 101, Manhattan, KS 66502
Phone: 785-236-1180    Fax: 785-789-4048
Dr. Sandrajean Mccoy Kramos, PH.D.
Psychologist
Medicare: Accepting Medicare Assignments
Practice Location: 400 Osage St., Manhattan, KS 66502
Phone: 785-539-9600    Fax: 785-537-6280
Dr. Lisa S Toburen, PHD
Psychologist
Medicare: Accepting Medicare Assignments
Practice Location: 720 Poyntz Ave, Manhattan, KS 66502
Phone: 785-320-7331    
Dr. Chaz D Mailey, PSY.D.
Psychologist
Medicare: May Accept Medicare Assignments
Practice Location: 555 Poyntz Ave Ste 243, Manhattan, KS 66502
Phone: 785-537-6051    Fax: 844-222-3691
Dr. Barbara Ann Pearson, PSY.D.
Psychologist
Medicare: Not Enrolled in Medicare
Practice Location: 1125 Laramie St Ste D2, Manhattan, KS 66502
Phone: 785-564-1661    Fax: 785-537-1969

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.